Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance

Hepatology

Volumn 50, Issue 1, 2009, Pages 77-84

  Su, Qiaozhu ^a   Tsai, Julie ^a,b   Xu, Elaine ^a   Qiu, Wei ^a   Bereczki, Erika ^c   Santha, Miklos ^c   Adeli, Khosrow ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B100; APOLIPOPROTEIN B50; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; LIPID; OLEIC ACID; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; APOLIPOPROTEIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HAMSTER; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER DISEASE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; ENDOPLASMIC RETICULUM; LIVER; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CRICETINAE; ENDOPLASMIC RETICULUM; INSULIN RESISTANCE; LIPIDS; LIVER; MICE; STRESS, PHYSIOLOGICAL;

EID: 67651171781     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22960     Document Type: Article

References (33)

1. Taskinen MR. Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995;6:153-160.
2. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005;36:232-240. (Pubitemid 40755136)
3. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007;10:142-148. (Pubitemid 46220305)
4. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004;306:457-461. (Pubitemid 39372439)
5. Ozawa K, Miyazaki M, Matsuhisa M, Takano K, Nakatani Y, Hatazaki M, et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 2005;54:657-663. (Pubitemid 40322067)
6. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107:1263-1273. (Pubitemid 32494543)
7. Lee JN, Gong Y, Zhang X, Ye J. Proteasomal degradation of ubiquitinated Insig proteins is determined by serine residues flanking ubiquitinated lysines. Proc Natl Acad Sci U S A 2006;103:4958-4963.
8. Liao W, Hui TY, Young SG, Davis RA. Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. J Lipid Res 2003;44:978-985. (Pubitemid 37279657)
9. Ota T, Gayet C, Ginsberg HN. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest 2008;118:316-332.
10. Kummrow E, Hussain MM, Pan M, Marsh JB, Fisher EA. Myristic acid increases dense lipoprotein secretion by inhibiting apoB degradation and triglyceride recruitment. J Lipid Res 2002;43:2155-2163. (Pubitemid 35471084)
11. Vukmirica J, Nishimaki-Mogami T, Tran K, Shan J, McLeod RS, Yuan J, et al. The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL. J Lipid Res 2002;43:1496-1507.
12. Su Q, Wang S, Baltzis D, Qu LK, Wong AH, Koromilas AE. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. Proc Natl Acad Sci U S A 2006;103:63-68. (Pubitemid 43076105)
13. Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A 2004;101:11269-11274.
14. Su Q, Wang S, Gao HQ, Kazemi S, Harding HP, Ron D, et al. Modulation of the eukaryotic initiation factor 2 alpha-subunit kinase PERK by tyrosine phosphorylation. J Biol Chem 2008;283:469-475.
15. Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999;397:271-274. (Pubitemid 29051178)
16. Urano F, Bertolotti A, Ron D. IRE1 and efferent signaling from the endoplasmic reticulum. J Cell Sci 2000;113(Pt 21):3697-3702. (Pubitemid 30943012)
17. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 1980;107:519-527.
18. Frame S, Cohen P, Biondi RM. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 2001;7:1321-1327. (Pubitemid 32607364)
19. Bjelik A, Bereczki E, Gonda S, Juhasz A, Rimanoczy A, Zana M, et al. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem Int 2006;49:393-400.
20. Scheuner D, Gromeier M, Davies MV, Dorner AJ, Song B, Patel RV, et al. The double-stranded RNA-activated protein kinase mediates viral-induced encephalitis. Virology 2003;317:263-274. (Pubitemid 38041170)
21. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003;11:619-633. (Pubitemid 36385118)
22. Roach PJ. Glycogen and its metabolism. Curr Mol Med 2002;2:101-120.
23. Brown AM, Gibbons GF. Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event. Arterioscler Thromb Vasc Biol 2001;21:1656-1661.
24. Diraison F, Beylot M. Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am J Physiol 1998;274(2 Pt 1):E321-E327. (Pubitemid 28140818)
25. Pan M, Liang JS, Fisher EA, Ginsberg HN. The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis. J Biol Chem 2002;277:4413-4421. (Pubitemid 34968708)
26. Dixon JL, Ginsberg HN. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J Lipid Res 1993;34:167-179.
27. Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, Le Tien H, Fantus IG, Lewis GF, et al. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 2002;277:793-803. (Pubitemid 34952120)
28. Fisher EA, Ginsberg HN. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem 2002;277:17377-17380.
29. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 2007;104:12587-12594. (Pubitemid 47255198)
30. Henry RR, Ciaraldi TP, Mudaliar S, Abrams L, Nikoulina SE. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes 1996;45:400-407. (Pubitemid 26110243)
31. MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, Drucker DJ, et al. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab 2007;6:329-337. (Pubitemid 47450185)
32. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, et al. Role that phosphorylation of GSK3 plays in insulin and Wnt signaling defined by knockin analysis. EMBO J 2005;24:1571-1583. (Pubitemid 40646447)
33. Liberman Z, Eldar-Finkelman H. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J Biol Chem 2005;280:4422-4428. (Pubitemid 40288606)